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(5.0%), normal sinus rhythm 208 times (38.4%). Interference wave of 131 times
(24.2%). (4) ILR patients during the follow-up period 17 cases (68%)with symp-
toms,13cases(52%) recorded to meaningful ECG was clear cause. 5 patients were
asymptomatic but records into meaningful ECG was diagnosed. 18 patients(72%) with
cardiac arrhythmias. (5) 18 cases of arrhythmia events recorded in patients by ILR, 2
cases not willing to once again ablation of atrial ﬂutter, 5 cases of atrial tachycardia
and 1 cases ventricular tachycardia in patients with antiarrhythmic drug therapy. 1
cases of before AF ablation with syncope symptom and paroxysmal atrial ﬁbrillation,
syncope again after ablation, ILR recorded syncope cause by ventricular tachycardia.
4 patients in sinus Beckoning bradycardia patients. After ablation of atrial ﬁbrillation
in 4 patients with atrial ﬁbrillation, 1 cases of recurrent AFL patient underwent
radiofrequency ablation. By the ILR, the 4 cases can be used to monitor the burden of
atrial ﬁbrillation in primary ablation: 25.711.4%, 23.97.5%, 19.15.6%,
18.73.2%.
Conclusions: ILR has the advantages of efﬁcient, safe, durable, high intelligence,
information can be stored. Model ILR can be obtained from the burden of atrial
ﬁbrillation, ventricular rate during atrial ﬁbrillation, the diurnal average heart rate,
heart rate variability and trends in activity. It provide objective basis for clinical
judgment, ablation of atrial ﬁbrillation occurred recurrence rate and other cardiac
events, and help for the reasonable application of anticoagulative drugs, help to reduce
the risk of ischemic and hemorrhagic events; anti arrhythmic drugs or radio frequency
ablation again provide reasonable and effective therapy.
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Combining use of Amiodarone and Esmolol In Management of Patients with
Ventricular Electrical Storm
He Yiping, Guo Hangyuan
Shaoxing People’s Hospital
Objectives: To analyze the management of ventricular electrical storm with amio-
darone and esmolol.
Methods: We conducted a retrospective analysis during last 5 years in our hospital.
To review and assess the causes, differential diagnosis and treatment with ventricular
electrical storm (VES). VES was deﬁned by 2 or more sustained episodes of ven-
tricular tachycardia or ventricular ﬁbrillation within 24 hours. All patients were treated
with electrical conversion or deﬁbrillation emergently, and treated with amiodarone, if
ineffective esmolol would be used.
Results: A total of 15 cases of ventricular electrical storm (ES) were included. Causes
of ventricular ES included: coronary atherosclerotic heart disease (n¼7), Brugada
syndrome (n¼1), Dilated cardiomyopathy (n¼3), Acute myocarditis (n¼1), Aconitine
poisoning (n¼1), Idiopathic ventricular tachycardia (n¼2). All patients were treated
with electrical conversion or deﬁbrillation emergently with averagely 4.5 times. All
cases were received intravenous injection of amiodarone,5 cases were effective ( the
effective rate was 33%).10 cases were resistant to amiodarone, and 7 cases were
successful managed by intravenous injection of esmolol (the effective rate was 70%).
3 cases were died within 24 hours, 12 cases were treated successfully (the total
effective rate of amiodarone and esmolol was 80%),After the ventricular ES subsided,
3 cases accepted ICD implantation, All 12 cases treated with amiodarone and betaloc
oral maintenance. 1 case died suddenly during a half year follow-up, None of VES
recurrence were monitored among the others.
Conclusions: Combining use of amiodarone and esmolol is effective in management
of patients with ventricular electrical storm, the early use of beta-blocking agent
especially esmolol should be considered.
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Catheter Ablation versus Antiarrhythmic Drugs for Atrial Fibrillation: An
Overview of Systematic Reviews
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Objectives: Atrial ﬁbrillation (AF) is the most frequent arrhythmia seen in clinical
practice. Antiarrhythmic drug (AAD) has a modest long-term efﬁcacy and the po-
tential for serious side effects. Catheter ablation (CA) is now considered as a viable
alternative to AAD in maintaining sinus rhythm in patients with AF. Numerous
systematic reviews (SRs) comparing CA with AAD for AF have already been pub-
lished. Then, it is necessary and important to summarise the results of these SRs in an
overview. To conduct an overview of SRs that evaluates the efﬁcacy and safety of CA
comparing with AAD for patients with AF.
Methods: We searched the Cochrane Library, PubMed, EMBASE, Web of Science
and Chinese databases (CBM, CNKI and Wanfang) electronically and also retrieved
papers from other sources, such as searching the reference lists of all included reviews
and carrying out a citation search of those papers which cited studies included in the
review. All relevant SRs were collected to compare CA with AAD for the mainte-
nance of sinus rhythm in patients with AF. There were no language restrictions, and
we did not restrict inclusion by the kinds of CA or AAD. Two investigators inde-
pendently screened studies, extracted data and assessed the methodological quality
according to appropriate criteria. Then all of these results were checked by a third
investigator. We conducted this overview of SRs by descriptive analysis.
Results: We identiﬁed seventeen SRs for inclusion within this overview altogether,
including one Cochrane reviews and sixteen non-Cochrane reviews. One paper was
published in Chinese and the others in English. Most of the included SRs have eligibleC166 JACC Vol 64/16/Suppl C j October 16–1methodological quality. A non-Cochrane systematic review showed similar survival of
patients with AF undergoing CA compared with AAD after 12 months of follow-up,
and with no difference in the rates of stroke or transient ischemic attack. Synthesized
results of other sixteen SRs demonstrated that CA is superior to AAD for patients with
paroxysmal or persistent AF, which was associated with higher efﬁcacy rates and a
lower rate of serious complications. Additionally, three SRs performed the economic
evaluation compared between CA and AAD, and the synthesized analysis indicated
that compared to the AAD strategy, CA had a higher costs with better effectiveness.
Conclusions: Evidence from the present SRs suggest that CA may be a better treat-
ment option compared to AAD in the management of AF. We can consider CA as a
relatively effective and well-tolerated procedure for maintaining sinus rhythm.
However, the comparison of long-term efﬁcacy and safety between CA and AAD, as
well as economic variable, should be further evaluated by more large sample and high
quality studies. Ongoing clinical trials in the future may provide further information
for guidance on these treatment options for AF.
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Radiofrequency catheter ablation Of right atrioventricular accessory pathway
via unconventional left subclavian veinous access
Zhang Yonghua, Xi Su, Jinglin Zhang
Wuhan Asia Heart Hospital
Objectives: To prove the effectiveness of radiofrequency catheter ablation (RFCA) of
right atrioventricular accessory pathway Via Left subclavian veinous Access.
Methods: 22 patients [14 men average age of (41.23.7) years old] underwent
conventional electrophysiological study and diagnostic Right Atrioventricular acces-
sory pathway, but unsuccessfully RFCA via femoral vein access. Try to RFCA via
unconventional left subclavian veinous access.
Results: The right atrioventricular accessory pathway were successfully eliminated by
RFCA in all 22 cases during operation. The sites of the accessory pathway were from
the right anterior septum in 3, the right free wall in 11, the right posterolater in 8 cases.
After ablation, no patient had recurrence. The success rate was 100%.
Conclusions: The anatomy of right atrioventricular accessory pathway is compara-
tively special. Occasionally, it is difﬁcult to RFCA via femoral vein access. It’s
suggested that RFCA of right atrioventricular accessory pathway by unconventional
left subclavian veinous access may be an alternative approach.
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Variation and signiﬁcance of serum CARP, hs-CRP in patients with atrial
ﬁbrillation
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Objectives: To explore the changes of serum levels of CARP, hs-CRP in patients with
atrial ﬁbrillation and its signiﬁcance, and survey the relationship among CARP, hs-
CRP and cardiac function.
Methods: 124 patients of our department were divided into atrial ﬁbrillation group
(n¼64) and sinusrhythm group (n¼60) according to ECG. The two groups were
divided into three subgroups (the NYHA class I, the NYHA class II and the NYHA
class III) according to the NYHA cardiac function class. On the second morning,
Serum CARP levels in all patients were measured by enzyme-linked immune sorbent
assay (ELISA), and serum hs-CRP levels were measured by latex enhance immune
and turbidimetric immunoassay (PETIA).Then the levels of them were dealed with
statistical analysis.
Results: (1) The levels of serum CARP, hs-CRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group (P<0.05).In the same NYHA
class subgroup, the levels of serum CARP, hs-CRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group (P<0.05). (2) The levels of
serum CARP, hs-CRP both in atrial ﬁbrillation group and in sinus rhythm group were
in sequence increased signiﬁcantly with the NYHA class (P<0.05).
Conclusions: (1) The levels of serum CARP, hsCRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group. The levels of serum CARP and
hsCRP were signiﬁcantly increased with the deterioration of cardiac function. (2)
CARP and hsCRP may be involved in the occurrence and sustainment of atrial
ﬁbrillation. The levels of serum CARP, hsCRP may serve as an independent index of
atrial ﬁbrillation.
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Efﬁcacy of adjunctive ablation of complex fractionated atrial electrograms and
pulmonary vein isolation in patients with atrial ﬁbrillation: a meta-analysis
Wen Junjie, Yi Guangzhao, He Quan, Zhou Hongyu, Luo Suxin
The First Afﬁliated Hospital of Chongqing Medical University
Objectives: To compare the efﬁcacy and safety of pulmonary vein isolation (PVI)
versus PVI plus adjunctive ablation of complex fractionated atrial electrograms
(CFAEs) in patients with atrial ﬁbrillation (AF) after a single procedure.
Methods: Literature search was conducted in PubMed, EMBASE, Cochrane Library,
CBM, Elsevier, CNKI and VIP for the clinical controlled trials of PVI versus PVI plus
adjunctive ablation of CFAEs in patients with AF, from January 1, 1980 to August 31,9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
2012. The references in the included literature were also retrieved. The extracted data
were analyzed using RevMan 5.1 software.
Results: Twelve qualiﬁed trials involving 1,131 AF patients were included. The re-
sults of meta-analysis showed that: in an overall pooled estimation, compared with
PVI alone, the rates of sinus rhythm maintenance (relative risk 1.17, 95% conﬁdence
interval 1.04-1.32, P¼0.008) were increased by PVI plus adjunctive ablation of
CFAEs. Subgroup analysis demonstrated that PVI plus adjunctive ablation of CFAEs
increased the rates of sinus rhythm maintenance in paroxysmal AF (relative risk 1.12,
95% conﬁdence interval 1.01-1.24, P¼0.03) and persistent AF (relative risk 1.32, 95%
conﬁdence interval 1.14-1.53, P¼0.0003). Adjunctive ablation of CFAEs signiﬁcantly
increased mean procedural, mean ﬂuoroscopy, and mean radiofrequency (RF) appli-
cation time. The incidence rate of complications was not signiﬁcantly different be-
tween the two groups (P¼0.85).
Conclusions: PVI followed by adjunctive ablation of CFAEs increases the rate of
long-term sinus rhythm maintenance in patients. Adjunctive ablation of CFAEs in-
creases procedural, ﬂuoroscopy, and RF application time. The risk/beneﬁt proﬁle of
adjunctive ablation of CFAEs needs further evaluation with additional studies and
long-term follow-up.
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Long-term follow-up after initial ablation for patients with paroxysmal
atrial ﬁbrillation between saline-irrigated radiofrequency catheter and
cryoballoon
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Gerds-Li Jinhong2, Pihua Fang1, Shu Zhang1
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Objectives: To analyzes the difference of the safety and effectiveness of pulmonary
vein isolation (PVI), the outcome of long-term follow-up after ﬁrst-time ablation
between saline-irrigated radiofrequency catheter ablation (RFCA) and cryoballoon
ablation (CBA) for patients with aroxysmal atrial ﬁbrillation (PAF).
Methods: The inpatient, operating and outpatient data of patients with PAF who had
ﬁrst-time received catheter ablation from January 2011 to June 2013 were retro-
spectively analyzed. The patients were divided into two groups basing on the ablation
management, the CBA group and the RFCA group. Failed-treatment of ablation was
deﬁned as any detected episode of AF, atrial ﬂutter, or atrial tachycardia which lasted
for 30 seconds after 3 months.
Results: A total of 158 patients were enrolled (CBA: 103/RFCA: 55). There were no
difference on the immediate rate of PVI archivement (98.3% vs. 98.1%) and the
incidence rate of procedure-related complications (2.9% vs. 3.6%). The CBA group
had a shorter the mean time(20[14, 32]min vs. 28 [16, 43] min, P<0.0001) and a lower
mean accumulated dosage of X-ray exposure (39783 [24528, 2455559] mGy/cm2 vs.
63306 [26478, 138753] mGy/cm2, P¼0.0007), a shorter mean procedure time (115
[80, 151] min vs. 159 [120,218] min, P<0.0001) and a shorter mean ablation time (35
[24, 55] min vs. 49 [17,71] min, P¼0.0004) than the RFCA group. During a mean
188 months follow-up, 37 patients were lost to follow up, and the successful-
treatment rate was 66.9% (81/121). There was no difference of the successful-treat-
ment rates between the CBA group and the RFCA group on the 3rd, 6th, 9th, 12th,
24th, 30th follow up (CBA group: 95.8%, 85.9%, 76.1%, 69.0%, 60.6%, 60.6% in
sequence; RFCA group: 90.0%, 78.0%, 78.0%, 78.0%, 72.0%, 72.0% in sequence).
Conclusions: CBA, as same as RFCA, can archive the high safety and the effec-
tiveness of immediately PVI, the long-term follow-up outcome for patients with PAF.
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Radiofrequency catheter ablation via radial artery approach for left-sided
atrioventricuar accessory pathways
Yin Yanlong, Yao Mingkai
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Objectives: To explore a new ablation approach of radial artery for left-sided atrio-
ventricuar accessory pathways (AP) ablation.
Methods: 26 patients with type A Wolff-Parkinson-White syndrome (WPW syn-
drome) and diameter of radial artery 2.5mm were selected. A 7F ablation catheter
was used via radial artery approach for mapping and ablation along a BMW guide-
wire. Two 6F sheathing canals were placed in the internal jugular vein or the sub-
clavian vein by which coronary sinus electrode and the right ventricular electrode
were placed.
Results: 24 cases were successful via radial artery approach, and 2 cases was failed by
this approach because of radial artery spasm. All patients were followed up for
(61.6) months and no recurrence was noted.
Conclusions: Assisted by mapping catheters placed through the internal jugular vein
or the subclavian vein, EP test and ablation for the left side AP can be effectively and
safety applied via the radial artery approach.
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Clinical research of the change of cardiac ankyrin repeat protein and brain
natriuretic peptide in patients with heart failure
Chen Moshui
Department of Cardiology, Afﬁliated to Haikou Hospital Xiangya School of Medicine
Central South UniversityJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CObjectives: To investigate the change of cardiac ankyrin repeat protein(CARP) in
the blood of patients with heart failure and the correlation among CARP, brain
natriuretic peptide (BNP) and left ventricular ejection fraction(LVEF) in the same
patients.
Methods: A total of 120 patients with heart failure and 30 healthy individuals May
2011 to March 2012 in our department of cardiology were enrolled in this study.
According to the New York heart (NYHA) classiﬁcation criteria, the patients with
heart failure were divided into four subgroups (the NYHA class I, the NYHA class
II, the NYHA class III and the NYHA class IV).3ml blood of antecubital vein
from patients with heart failure were collected at admission and 3ml blood of
antecubital vein from healthy individuals on an empty stomach in early morning.
Added Na2 – ethylenediaminetetra - acetic acid to the samples of whole blood,
separated plasma by prompt centrifugation of the blood samples at 3000g at room
temperature for 15 minutes. The samples were immediately frozen and stored at
-20C. And the functional parameter of left ventricular contraction were collected
by Ultrasonic cardiography (UCG), including left ventricular ejection fraction.
After collected all specimens, the CARP and BNP were detected using method of
ELISA. The relationship of CARP and patients with heart failure and BNP was
investigated.
Results: The levels of serum CARP (21.248.30ng/mL) were signiﬁcantly higher in
patients with heart failure than those in control subjects (8.301.45ng/mL) (P <0.05).
The levels of serum CARP increased with increment of degree of severity of heart
failure according to the NYHA classiﬁcation and the differences between the groups
of classI, classII, class III and class IV were signiﬁcant (P<0.01).The correlation
between levels of serum CARP and BNP was positive (r¼0.917, P<0.01).The levels
of serum CARP negatively correlated with left ventricular ejection fraction(r¼-0.848,
P<0.01).
Conclusions: CARP is closely related to BNP and patients with heart failure, which
demonstrate that CARP testing might can be new biochemical markers of helpful to
assist diagnosing heart failure.
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Objectives: The aim of this study was to investigate the predictive value of
CHA2DS2-VASc score for left ventricular mechanics impairment and intra-ventricular
dyssynchrony in patients with atrial ﬁbrillation.
Methods: Echocardiographic examinations were performed in 100 patients with
nonvalvular atrial ﬁbrillation and 43 control subjects. Global longitudinal strain
(GLS) and circumferential strain (GCS) were acquired as a measure of longitudinal
and circumferential systolic mechanics while early diastolic global longitudinal
strain rate (eGLSR) and circumferential strain rate (eGCSR) were acquired as a
measure of longitudinal and circumferential diastolic mechanics of left ventricle
respectively. Standard deviation of time to regional peak longitudinal strain
(SDT-S) and early diastolic strain rate (SDT-eSR) were acquired as a measure of
intra-ventricular dyssynchrony. Both the whole subjects and the subjects with
atrial ﬁbrillation were divided into three groups: low-risk group (CHA2DS2-
VASc¼0), moderate-risk group (CHA2DS2-VASc¼1) and high-risk group
(CHA2DS2-VASc 2).
Results: In the whole subjects, GLS was signiﬁcantly reduced in high-risk group
than in low-risk group (14.294.38% vs. 16.833.43%, P<0.01) and moderate-
risk group (14.294.38% vs. 17.124.18%, P<0.01). EGCSR was lower in high-
risk patients than low-risk patients (1.930.76/s vs. 2.410.90/s, P<0.05) while
SDT-eSR was signiﬁcantly higher in high-risk patients than low-risk (49.4123.44
ms vs. 38.7812.87 ms, P<0.05) and moderate-risk patients (49.4123.44 ms
vs. 37.8117.15 ms, P<0.05). Subgroup comparison between subjects with
atrial ﬁbrillation and the control subjects revealed GCS (19.598.50% vs.
29.685.36%, P <0.001), GLS (15.454.48% vs. 18.873.04%, P¼0.005) and
eGCSR (1.990.78/s vs. 2.610.76/s, P¼0.019) were signiﬁcantly reduced in
subjects with atrial ﬁbrillation than control subjects while SDT-eSR was higher
(4420 ms vs. 319 ms, P¼0.010) in subjects with atrial ﬁbrillation than in
control subjects. Stepwise multivariate regression analysis revealed CHA2DS2-
VASc score to be an independent predictor of LVEF and GLS in the whole
subjects (b¼-0.33, adjusted R2¼0.10, P<0.001; b¼-0.29, adjusted R2¼0.34,
P¼0.001) and in subjects with atrial ﬁbrillation (b¼-0.32, adjusted R2¼0.09,
P¼0.002; b¼-0.26, adjusted R2¼0.29, P¼0.010) as well. Stepwise multivariate
regression analysis revealed CHA2DS2-VASc score to be an independent predictor
of eGLSR and eGCSR in the whole subjects (b¼-0.27, adjusted R2¼0.07,
P¼0.007; b¼-0.24, adjusted R2¼0.13, P¼0.020) and in subjects with atrial
ﬁbrillation (b¼-0.31, adjusted R2¼0.09, P¼0.007; b¼-0.25, adjusted R2¼0.05,
P¼0.047) as well. Stepwise multivariate regression analysis revealed CHA2DS2-ardiovascular Disease Clinical Research C167
